电子烟使用与类风湿关节炎及系统性红斑狼疮发病风险:All of Us研究项目
基于All of Us研究项目数据,将当前电子烟使用者按年龄、性别、种族/民族、入组年份和吸烟状态匹配非使用者,随访至RA或SLE首次发生、死亡、研究结束(2023年10月1日)或满5年。结果显示当前电子烟使用与RA或SLE发病风险升高相关(调整HR 1.49,95%CI 1.01-2.20)。
要点
- 当前电子烟使用者较匹配非使用者RA或SLE发病风险升高(调整HR 1.49)。
- 分层分析中,既往或当前吸烟者中电子烟使用风险更高,RA和SLE均见升高但样本量较小。
- 需进一步研究评估剂量-反应关系。
核心结论
- 当前电子烟使用与类风湿关节炎或系统性红斑狼疮发病风险升高相关。
研究设计与样本
- 利用All of Us研究项目(版本8)数据,将当前电子烟使用者按年龄、性别、种族/民族、入组年份和吸烟状态匹配非使用者。
- 随访从入组至RA或SLE首次发生、死亡、研究结束(2023年10月1日)或满5年,以先发生者为准。
主要发现
- 当前电子烟使用者中发生66例RA或SLE,46,038人年,发病率1.43/1000人年。
- 匹配非使用者中发生43例,46,203人年,发病率0.93/1000人年。
- 发病率比IRR 1.54(95%CI 1.05-2.26),调整后HR 1.49(95%CI 1.01-2.20)。
- 分层分析中,既往或当前吸烟者中电子烟使用者风险高于非使用者,RA和SLE均升高但样本量较小。
临床怎么用
- 在风湿免疫科评估RA或SLE风险时,可将当前电子烟使用纳入病史采集。
- 对既往或当前吸烟且使用电子烟者,应关注RA或SLE相关症状监测。
局限性
- 分层分析中RA和SLE样本量较小。
- 需进一步研究评估剂量-反应关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Electronic cigarettes (e-cigarettes) are increasingly used as a substitute or in addition to cigarettes. Although cigarette smoking is a well-established risk factor for both rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), the association between e-cigarette use and the development of RA or SLE remains unclear. We investigated e-cigarette use and the risk of incident RA or SLE. METHODS: Using All of Us Research Program (version 8) data, e-cigarette current users were matched by age, sex, race/ethnicity, enrollment year, and cigarette smoking status to non-users, and followed from enrollment until 1st occurrence of RA or SLE, death, end of study period (October 1, 2023), or up to 5 years, whichever first. We estimated incidence rates (IR) and incidence rate ratios (IRR), and calculated hazard ratios (HRs) using Cox models adjusting for other potential confounders. We also performed smoking- and disease state-stratified analyses. RESULTS: We identified 15,909 e-cigarette current users and matched non-users. A total of 66 cases of RA or SLE developed among current e-cigarette users in 46,038 person-years vs (IR 1.43/1000 person-years) vs. 43 incident cases among matched non-users in 46,203 person-years (IR 0.93/1000 person-years; IRR 1.54, 95% CI 1.05-2.26; adjusted HR 1.49; 95% CI 1.01-2.20). In stratified analyses, risks were higher among e-cigarette users than non-users who were past or current smokers, and elevated for both RA and SLE, although with smaller sample sizes. CONCLUSIONS: Current e-cigarette use was associated with an increased risk of RA or SLE. Further studies are needed to evaluate dose-response relationships.
引用
- Yee J, Oakes EG, Santacroce L, et al. Electronic cigarette use and risk of incident rheumatoid arthritis and systemic lupus erythematosus in the all of us research program. Semin Arthritis Rheum. 2026. PMID: 42659936. doi:10.1016/j.semarthrit.2026.153058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。